Prognostic variables in patients with chronic myeloid leukemia treated with imatinib.
Gambacorti-Passerini
Carlo
C
University of Milano Bicocca, Monza, Italy. carlo.gambacorti@unimib.it
D001549:Benzamides; D020732:Cytogenetic Analysis; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011379:Prognosis; D011743:Pyrimidines / Q000627:therapeutic use*; D055502:Secondary Prevention
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate